Search for: "Freedom Pharmaceuticals, Inc" Results 1 - 20 of 109
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Aug 2020, 5:22 am by Russell Beck
Pursuant to a settlement with another biotechnology company, defendant Biogen, Inc. [read post]
31 May 2020, 4:22 pm by INFORRM
Ireland Ireland’s defamation regime is having a detrimental impact on press freedom and the commercial viability of the press, the Press Council of Ireland and the Office of the Press Ombudsman have said. [read post]
20 May 2020, 1:58 pm by Jason Rantanen
Over twenty of Japan’s major corporations have made a similar commitment to not assert some 300,000 patents through the Open Covid-19 Declaration, including two leading suppliers of COVID tests, LSI Medience and SRL Inc, and Teijin Limited, a Japanese pharmaceutical and information technology company. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
Both the Federal Circuit and the predecessor Court of Claims have deemed reasonable royalty awards to be “the preferred manner” of compensation under section 1498; in Tektronix Inc. v. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
Both the Federal Circuit and the predecessor Court of Claims have deemed reasonable royalty awards to be “the preferred manner” of compensation under section 1498; in Tektronix Inc. v. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
” Israel invoked an emergency patent-suspension clause, allowing it to import a generic version of anti-viral drug Kaletra produced by AbbVie Inc. [read post]
18 Feb 2020, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) or Frye v. [read post]
28 Jan 2020, 9:58 pm by Cynthia Marcotte Stamer
  Utilizing the flexibility resulting from the Coix Order could help reduce health plan costs of compliance with the HIPAA right of access rule by allowing the health plan and its records providers more freedom to determine the charges and format for delivering PHI in response to records requests received from other insurers, lawyers and other third parties. [read post]
28 Jan 2020, 12:06 am
The conference will feature representatives from major industry players (including FIFA, NBA Properties, Inc., Ubisoft Entertainment and more), sessions examining dynamic and emerging issues related to traditional sports and the growing esports industry, as well as looking at woken in sports. [read post]
1 Dec 2019, 7:09 pm by Andrew Murray
  It also addresses allegations against another Fagron subsidiary, B&B Pharmaceuticals Inc. [read post]
28 Nov 2019, 10:39 am
| IPEC no longer London-focuses as IP small claims track reaches courts in Newcastle, Manchester, Cardiff and beyond | Can an employee’s freedom of expression trump their confidentiality obligations? [read post]
4 Oct 2019, 4:38 pm by Unknown
And in domains where the Court is content to review only a small fraction of cases, the lower courts retain significant freedom to deviate from the deference and categorical rules predicted by the judicial capacity model in capacity-constrained domains. [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]
4 Jun 2019, 9:30 pm by Mitra Sharafi
Indeed, in 1860s-1870s my protagonists believed that the implementation of new procedures would guarantee that fair trial would bring freedom and dignity. [read post]
11 Mar 2019, 7:08 pm by Dennis Crouch
Momenta argued in briefing and at oral argument that the inter partes review was akin to an expensive “freedom-to-operate” action that resulted in immediate harm, presenting a “fork in the road” in its development process. [read post]
28 Jan 2019, 7:17 am by Andrew Hamm
Teva Pharmaceuticals USA Inc., in which the court held that the sale of an invention to a third party who is obligated to keep the invention confidential may place the invention “on sale” for purposes of the Leahy-Smith America Invents Act. [read post]
10 Aug 2018, 12:56 am by Sander van Rijnswou
After the EPO send out an intention to grant in the patent application, entitlement proceedings against the patent were started before the District Court of The Hague (Article 61 proceedings). [read post]